Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Elaine Morrato

TitleProfessor Adjunct
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentCSPH-HSMP General Ops
Phone303/724-4760

    Collapse Research 
    Collapse research activities and funding
    R21MH097045     (MORRATO, ELAINE H)Dec 4, 2012 - Nov 30, 2015
    NIH
    Metabolic Screening: Prioritizing Implementation Strategies for Mental Health
    Role: Principal Investigator

    R13HS023723     (MORRATO, ELAINE H)Nov 15, 2014 - Nov 14, 2016
    NIH
    Implementation Research Agenda: Appropriate Use of Clinical Preventive Services
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Morrato EH. Interpreting evidence on long-acting injectable antipsychotics. Lancet Psychiatry. 2021 05; 8(5):349-351. PMID: 33862019.
      View in: PubMed
    2. Risendal BC, Hébert JR, Morrato EH, Thomson CA, Escoffery CN, Friedman DB, Dwyer AJ, Overholser LS, Wheeler SB. Addressing COVID-19 Using a Public Health Approach: Perspectives From the Cancer Prevention and Control Research Network. Am J Prev Med. 2021 06; 60(6):877-882. PMID: 33785276.
      View in: PubMed
    3. Lind KE, Hildreth K, Lindrooth R, Morrato E, Crane LA, Perraillon MC. The effect of direct cognitive assessment in the Medicare annual wellness visit on dementia diagnosis rates. Health Serv Res. 2021 Apr; 56(2):193-203. PMID: 33481263.
      View in: PubMed
    4. Thomson CA, Overholser LS, Hébert JR, Risendal BC, Morrato EH, Wheeler SB. Addressing Cancer Survivorship Care Under COVID-19: Perspectives From the Cancer Prevention and Control Research Network. Am J Prev Med. 2021 05; 60(5):732-736. PMID: 33663935.
      View in: PubMed
    5. Nearing K, Rainwater J, Neves S, Bhatti P, Conway B, Hafer N, Harter K, Kenyon N, McManus MM, McNeal DM, Morrato EH, Rajguru SM, Wasko M. I-Corps@NCATS trains clinical and translational science teams to accelerate translation of research innovations into practice. J Clin Transl Sci. 2020 Dec 07; 5(1):e66. PMID: 33948285.
      View in: PubMed
    6. Morrato EH, Lennox LA, Sendro ER, Schuster AL, Pincus HA, Humensky J, Firestein GS, Nadler LM, Toto R, Reis SE. Scale-up of the Accrual to Clinical Trials (ACT) network across the Clinical and Translational Science Award Consortium: a mixed-methods evaluation of the first 18 months. J Clin Transl Sci. 2020 Jun 30; 4(6):515-528. PMID: 33948228.
      View in: PubMed
    7. Russell AM, Morrato EH, Lovett RM, Smith MY. Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review. Drug Saf. 2020 05; 43(5):427-446. PMID: 32020558.
      View in: PubMed
    8. Toyserkani GA, Huynh L, Morrato EH. Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014-2018) Using RE-AIM. Front Public Health. 2020; 8:43. PMID: 32158741.
      View in: PubMed
    9. McManus BM, Richardson Z, Schenkman M, Murphy NJ, Everhart RM, Hambidge S, Morrato E. Child characteristics and early intervention referral and receipt of services: a retrospective cohort study. BMC Pediatr. 2020 02 22; 20(1):84. PMID: 32087676.
      View in: PubMed
    10. McManus BM, Murphy NJ, Richardson Z, Khetani MA, Schenkman M, Morrato EH. Family-centred care in early intervention: Examining caregiver perceptions of family-centred care and early intervention service use intensity. Child Care Health Dev. 2020 01; 46(1):1-8. PMID: 31782824.
      View in: PubMed
    11. Brewer SE, Campagna EJ, Morrato EH. Advancing regulatory science and assessment of FDA REMS programs: A mixed-methods evaluation examining physician survey response. J Clin Transl Sci. 2019 Aug; 3(4):199-209. PMID: 31660244.
      View in: PubMed
    12. Morrato EH, Hamer MK, Sills M, Kwan B, Schilling LM. Applying a Commercialization-Readiness Framework to Optimize Value for Achieving Sustainability of an Electronic Health Data Research Network and Its Data Capabilities: The SAFTINet Experience. EGEMS (Wash DC). 2019 Aug 29; 7(1):48. PMID: 31523697.
      View in: PubMed
    13. Ford B, Rabin B, Morrato EH, Glasgow RE. Online Resources for Dissemination and Implementation Science: Meeting Demand and Lessons Learned. J Clin Transl Sci. 2018 Oct; 2(5):259-266. PMID: 31223491.
      View in: PubMed
    14. McManus BM, Richardson Z, Schenkman M, Murphy N, Morrato EH. Timing and Intensity of Early Intervention Service Use and Outcomes Among a Safety-Net Population of Children. JAMA Netw Open. 2019 01 04; 2(1):e187529. PMID: 30681716.
      View in: PubMed
    15. Lind KE, Hildreth K, Lindrooth R, Crane LA, Morrato E, Perraillon MC. Ethnoracial Disparities in Medicare Annual Wellness Visit Utilization: Evidence From a Nationally Representative Database. Med Care. 2018 09; 56(9):761-766. PMID: 30015726.
      View in: PubMed
    16. Morrato EH. Implementation Science: Ensuring the Return on Our Research Investment. Neurorehabil Neural Repair. 2018 09; 32(9):762-764. PMID: 30129390.
      View in: PubMed
    17. Visweswaran S, Becich MJ, D'Itri VS, Sendro ER, MacFadden D, Anderson NR, Allen KA, Ranganathan D, Murphy SN, Morrato EH, Pincus HA, Toto R, Firestein GS, Nadler LM, Reis SE. Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network. JAMIA Open. 2018 Oct; 1(2):147-152. PMID: 30474072.
      View in: PubMed
    18. Lind KE, Hildreth K, Lindrooth R, Morrato E, Crane LA, Perraillon MC. Effect of Medicare Part D on Ethnoracial Disparities in Antidementia Medication Use. J Am Geriatr Soc. 2018 09; 66(9):1760-1767. PMID: 30095169.
      View in: PubMed
    19. Smith MY, Russell A, Bahri P, Mol PGM, Frise S, Freeman E, Morrato EH. The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products. Drug Saf. 2018 Apr; 41(4):389-401. PMID: 29218682.
      View in: PubMed
    20. Holtrop JS, Ruland S, Diaz S, Morrato EH, Jones E. Using Social Network Analysis to Examine the Effect of Care Management Structure on Chronic Disease Management Communication Within Primary Care. J Gen Intern Med. 2018 05; 33(5):612-620. PMID: 29313225.
      View in: PubMed
    21. Morrato EH. The Case for Funding Our National Drug Safety Surveillance System. Med Care. 2017 06; 55(6):543-544. PMID: 28452868.
      View in: PubMed
    22. Feinstein JA, Morrato EH, Feudtner C. Prioritizing Pediatric Drug Research Using Population-Level Health Data. JAMA Pediatr. 2017 01 01; 171(1):7-8. PMID: 27893067.
      View in: PubMed
    23. Morrato EH, Campagna EJ, Brewer SE, Dickinson LM, Thomas DS, Miller BF, Dearing J, Druss BG, Lindrooth RC. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals. JAMA Psychiatry. 2016 Jul 01; 73(7):721-30. PMID: 27167755.
      View in: PubMed
    24. Morrato EH, Brewer SE, Campagna EJ, Dickinson LM, Thomas DS, Druss BG, Miller BF, Newcomer JW, Lindrooth RC. Glucose Testing for Adults Receiving Medicaid and Antipsychotics: A Population-Based Prescriber Survey on Behaviors, Attitudes, and Barriers. Psychiatr Serv. 2016 07 01; 67(7):798-802. PMID: 27032657.
      View in: PubMed
    25. Merchant AT, Nahhas GJ, Wadwa RP, Zhang J, Tang Y, Johnson LR, Maahs DM, Bishop F, Teles R, Morrato EH. Periodontal Microorganisms and Cardiovascular Risk Markers in Youth With Type 1 Diabetes and Without Diabetes. J Periodontol. 2016 Apr; 87(4):376-84. PMID: 26616842.
      View in: PubMed
    26. Radawski C, Morrato E, Hornbuckle K, Bahri P, Smith M, Juhaeri J, Mol P, Levitan B, Huang HY, Coplan P, Li H. Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist. Pharmacoepidemiol Drug Saf. 2015 Dec; 24(12):1233-40. PMID: 26456379.
      View in: PubMed
    27. Nicol GE, Campagna EJ, Garfield LD, Newcomer JW, Parks JJ, Morrato EH. The Role of Clinical Setting and Management Approach in Metabolic Testing Among Youths and Adults Treated With Antipsychotics. Psychiatr Serv. 2016 Jan; 67(1):128-32. PMID: 26325456.
      View in: PubMed
    28. Morrato EH, Rabin B, Proctor J, Cicutto LC, Battaglia CT, Lambert-Kerzner A, Leeman-Castillo B, Prahl-Wretling M, Nuechterlein B, Glasgow RE, Kempe A. Bringing it home: expanding the local reach of dissemination and implementation training via a university-based workshop. Implement Sci. 2015 Jul 04; 10:94. PMID: 26141909.
      View in: PubMed
    29. Morrato EH, Smith MY. Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved. Ther Clin Risk Manag. 2015; 11:339-48. PMID: 25750537.
      View in: PubMed
    30. Morrato EH, Parks J, Campagna EJ, Muser E, Thomas DS, Fang H, Doshi D. Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence. J Comp Eff Res. 2015 Mar; 4(2):89-99. PMID: 25251693.
      View in: PubMed
    31. Morrato EH. Capsule commentary on Sabbatini et al., controlling health costs: physician responses to patient expectations for medical care. J Gen Intern Med. 2014 Sep; 29(9):1272. PMID: 24993085.
      View in: PubMed
    32. Root ED, Thomas DS, Campagna EJ, Morrato EH. Adjusting for geographic variation in observational comparative effectiveness studies: a case study of antipsychotics using state Medicaid data. BMC Health Serv Res. 2014 Aug 27; 14:355. PMID: 25164423.
      View in: PubMed
    33. Smith MY, Morrato E. Advancing the field of pharmaceutical risk minimization through application of implementation science best practices. Drug Saf. 2014 Aug; 37(8):569-80. PMID: 25005707.
      View in: PubMed
    34. Campagna EJ, Muser E, Parks J, Morrato EH. Methodological considerations in estimating adherence and persistence for a long-acting injectable medication. J Manag Care Spec Pharm. 2014 Jul; 20(7):756-66. PMID: 24967528.
      View in: PubMed
    35. Sømme S, Bronsert M, Morrato E, Ziegler M. Frequency and variety of inpatient pediatric surgical procedures in the United States. Pediatrics. 2013 Dec; 132(6):e1466-72. PMID: 24276846.
      View in: PubMed
    36. Barnard JG, Albright K, Morrato EH, Nowels CT, Benefield EM, Hadley-Miller NA, Kempe A, Erickson MA. Paediatric spinal fusion surgery and the transition to home-based care: provider expectations and carer experiences. Health Soc Care Community. 2013 Nov; 21(6):634-43. PMID: 23647700.
      View in: PubMed
    37. Morrato EH, Concannon TW, Meissner P, Shah ND, Turner BJ. Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions. J Comp Eff Res. 2013 Mar; 2(2):185-94. PMID: 24236560.
      View in: PubMed
    38. Erickson MA, Morrato EH, Campagna EJ, Elise B, Miller NH, Kempe A. Variability in spinal surgery outcomes among children's hospitals in the United States. J Pediatr Orthop. 2013 Jan; 33(1):80-90. PMID: 23232385.
      View in: PubMed
    39. Victoroff MS, Drury BM, Campagna EJ, Morrato EH. Impact of electronic health records on malpractice claims in a sample of physician offices in Colorado: a retrospective cohort study. J Gen Intern Med. 2013 May; 28(5):637-44. PMID: 23192449.
      View in: PubMed
    40. Morrato EH, Ling SB. The Drug Safety and Risk Management Advisory Committee: a case study of meeting frequency, content, and outcomes before and after FDAAA. Med Care. 2012 Nov; 50(11):970-86. PMID: 23047787.
      View in: PubMed
    41. Morrato EH, Allison DB. FDA approval of obesity drugs: a difference in risk-benefit perceptions. JAMA. 2012 Sep 19; 308(11):1097-8. PMID: 22990266.
      View in: PubMed
    42. Gohlke JM, Dhurandhar EJ, Correll CU, Morrato EH, Newcomer JW, Remington G, Nasrallah HA, Crystal S, Nicol G, Allison DB. Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs. Front Psychiatry. 2012; 3:62. PMID: 22754543.
      View in: PubMed
    43. Concannon TW, Meissner P, Grunbaum JA, McElwee N, Guise JM, Santa J, Conway PH, Daudelin D, Morrato EH, Leslie LK. A new taxonomy for stakeholder engagement in patient-centered outcomes research. J Gen Intern Med. 2012 Aug; 27(8):985-91. PMID: 22528615.
      View in: PubMed
    44. Sømme S, Bronsert M, Kempe A, Morrato EH, Ziegler M. Alignment of training curriculum and surgical practice: implications for competency, manpower, and practice modeling. Eur J Pediatr Surg. 2012 Feb; 22(1):74-9. PMID: 22434230.
      View in: PubMed
    45. Merchant AT, Oranbandid S, Jethwani M, Choi YH, Morrato EH, Pitiphat W, Mayer-Davis EJ. Oral care practices and A1c among youth with type 1 and type 2 diabetes. J Periodontol. 2012 Jul; 83(7):856-63. PMID: 22141359.
      View in: PubMed
    46. Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011 Jun; 49(6):599-604. PMID: 21577183.
      View in: PubMed
    47. Fox D, Morrato E, Campagna EJ, Rees DI, Dickinson LM, Partrick DA, Kempe A. Outcomes of laparoscopic versus open fundoplication in children's hospitals: 2005-2008. Pediatrics. 2011 May; 127(5):872-80. PMID: 21502226.
      View in: PubMed
    48. Merchant AT, Jethwani M, Choi YH, Morrato EH, Liese AD, Mayer-Davis E. Associations between periodontal disease and selected risk factors of early complications among youth with type 1 and type 2 diabetes: a pilot study. Pediatr Diabetes. 2011 Sep; 12(6):529-35. PMID: 21392193.
      View in: PubMed
    49. Nicol GE, Morrato EH, Johnson MC, Campagna E, Yingling MD, Pham V, Newcomer JW. Best practices: implementation of a glucose screening program based on diffusion of innovation theory methods. Psychiatr Serv. 2011 Jan; 62(1):12-4. PMID: 21209293.
      View in: PubMed
    50. Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, Campagna E, Newcomer JW. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):66-75. PMID: 21182154.
      View in: PubMed
    51. Orlando VA, Johnson LR, Wilson AR, Maahs DM, Wadwa RP, Bishop FK, Dong F, Morrato EH. Oral Health Knowledge and Behaviors among Adolescents with Type 1 Diabetes. Int J Dent. 2010; 2010:942124. PMID: 20490262.
      View in: PubMed
    52. Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, Campagna E, Newcomer JW. Metabolic screening in children receiving antipsychotic drug treatment. Arch Pediatr Adolesc Med. 2010 Apr; 164(4):344-51. PMID: 20368487.
      View in: PubMed
    53. Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010 Jan; 67(1):17-24. PMID: 20048219.
      View in: PubMed
    54. Banta JE, Morrato EH, Lee SW, Haviland MG. Retrospective analysis of diabetes care in California Medicaid patients with mental illness. J Gen Intern Med. 2009 Jul; 24(7):802-8. PMID: 19415391.
      View in: PubMed
    55. Morrato EH, Newcomer JW, Kamat S, Baser O, Harnett J, Cuffel B. Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes. Diabetes Care. 2009 Jun; 32(6):1037-42. PMID: 19244091.
      View in: PubMed
    56. Morrato EH, Cuffel B, Newcomer JW, Lombardo I, Kamat S, Barron J. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients. J Clin Psychopharmacol. 2009 Feb; 29(1):26-32. PMID: 19142103.
      View in: PubMed
    57. Morrato EH, Dillon P, Ziegler M. Surgical outcomes research: a progression from performance audits, to assessment of administrative databases, to prospective risk-adjusted analysis - how far have we come? Curr Opin Pediatr. 2008 Jun; 20(3):320-5. PMID: 18475103.
      View in: PubMed
    58. Dillon P, Hammermeister K, Morrato E, Kempe A, Oldham K, Moss L, Marchildon M, Ziegler M, Steeger J, Rowell K, Shiloach M, Henderson W. Developing a NSQIP module to measure outcomes in children's surgical care: opportunity and challenge. Semin Pediatr Surg. 2008 May; 17(2):131-40. PMID: 18395663.
      View in: PubMed
    59. Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data. J Clin Psychiatry. 2008 Feb; 69(2):316-22. PMID: 18251625.
      View in: PubMed
    60. Morrato EH, Libby AM, Orton HD, Degruy FV, Brent DA, Allen R, Valuck RJ. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2008 Jan; 165(1):42-50. PMID: 17986680.
      View in: PubMed
    61. Morrato EH, Elias M, Gericke CA. Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA. J Public Health (Oxf). 2007 Dec; 29(4):463-71. PMID: 17942850.
      View in: PubMed
    62. Valuck RJ, Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R. How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs. Curr Med Res Opin. 2007 Oct; 23(10):2567-76. PMID: 17848204.
      View in: PubMed
    63. Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2007 Aug; 164(8):1198-205. PMID: 17671282.
      View in: PubMed
    64. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry. 2007 Jun; 164(6):884-91. PMID: 17541047.
      View in: PubMed
    65. Morrato EH, Hill JO, Wyatt HR, Ghushchyan V, Sullivan PW. Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care. 2007 Feb; 30(2):203-9. PMID: 17259482.
      View in: PubMed
    66. Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Clin Ther. 2007 Jan; 29(1):183-95. PMID: 17379060.
      View in: PubMed
    67. Morrato EH, Staffa JA. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data. Pharmacoepidemiol Drug Saf. 2007 Jan; 16(1):104-12. PMID: 16821248.
      View in: PubMed
    68. McCollum M, Ellis SL, Morrato EH, Sullivan PW. Prevalence of multiple cardiac risk factors in US adults with diabetes. Curr Med Res Opin. 2006 Jun; 22(6):1031-4. PMID: 16846537.
      View in: PubMed
    69. Morrato EH, Hill JO, Wyatt HR, Ghushchyan V, Sullivan PW. Are health care professionals advising patients with diabetes or at risk for developing diabetes to exercise more? Diabetes Care. 2006 Mar; 29(3):543-8. PMID: 16505503.
      View in: PubMed
    70. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care. 2005 Jul; 28(7):1599-603. PMID: 15983307.
      View in: PubMed
    Morrato's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)